157 related articles for article (PubMed ID: 23066769)
1. Effects of N-acetyl cysteine on cognitive function in bipolar disorder.
Dean OM; Bush AI; Copolov DL; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
Psychiatry Clin Neurosci; 2012 Oct; 66(6):514-7. PubMed ID: 23066769
[TBL] [Abstract][Full Text] [Related]
2. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
[TBL] [Abstract][Full Text] [Related]
3. N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.
Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
J Affect Disord; 2011 Mar; 129(1-3):317-20. PubMed ID: 20800897
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.
McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH
Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220
[TBL] [Abstract][Full Text] [Related]
5. Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder.
Law CW; Soczynska JK; Woldeyohannes HO; Miranda A; Brooks JO; McIntyre RS
Pharmacol Biochem Behav; 2009 Mar; 92(1):12-6. PubMed ID: 18976682
[TBL] [Abstract][Full Text] [Related]
6. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
Chengappa KN; Bowie CR; Schlicht PJ; Fleet D; Brar JS; Jindal R
J Clin Psychiatry; 2013 Nov; 74(11):1076-83. PubMed ID: 24330893
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological performance in euthymic Indian patients with bipolar disorder type I: correlation between quality of life and global functioning.
Pattanayak RD; Sagar R; Mehta M
Psychiatry Clin Neurosci; 2012 Dec; 66(7):553-63. PubMed ID: 23252921
[TBL] [Abstract][Full Text] [Related]
8. A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania.
Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
Aust N Z J Psychiatry; 2013 Jun; 47(6):564-8. PubMed ID: 23493756
[TBL] [Abstract][Full Text] [Related]
9. Executive function and attention span in euthymic patients with bipolar 1 disorder.
Normala I; Abdul HA; Azlin B; Nik Ruzyanei NJ; Hazli Z; Shah SA
Med J Malaysia; 2010 Sep; 65(3):199-203. PubMed ID: 21939168
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
11. Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder.
Magalhães PV; Dean OM; Bush AI; Copolov DL; Weisinger D; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):132-5. PubMed ID: 22212173
[TBL] [Abstract][Full Text] [Related]
12. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
[TBL] [Abstract][Full Text] [Related]
13. Cognitive functioning in elderly patients with early onset bipolar disorder.
Schouws SN; Zoeteman JB; Comijs HC; Stek ML; Beekman AT
Int J Geriatr Psychiatry; 2007 Sep; 22(9):856-61. PubMed ID: 17262882
[TBL] [Abstract][Full Text] [Related]
14. Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
Rapado-Castro M; Dodd S; Bush AI; Malhi GS; Skvarc DR; On ZX; Berk M; Dean OM
Psychol Med; 2017 Apr; 47(5):866-876. PubMed ID: 27894373
[TBL] [Abstract][Full Text] [Related]
15. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
Young AH; Gallagher P; Watson S; Del-Estal D; Owen BM; Ferrier IN
Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode.
Torres IJ; DeFreitas VG; DeFreitas CM; Kauer-Sant'Anna M; Bond DJ; Honer WG; Lam RW; Yatham LN
J Clin Psychiatry; 2010 Sep; 71(9):1234-42. PubMed ID: 20361907
[TBL] [Abstract][Full Text] [Related]
18. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder.
López-Jaramillo C; Lopera-Vásquez J; Ospina-Duque J; García J; Gallo A; Cortez V; Palacio C; Torrent C; Martínez-Arán A; Vieta E
J Clin Psychiatry; 2010 Aug; 71(8):1055-60. PubMed ID: 20361895
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive impairment and psychosocial functioning in bipolar II disorder.
Solé B; Bonnin CM; Torrent C; Balanzá-Martínez V; Tabarés-Seisdedos R; Popovic D; Martínez-Arán A; Vieta E
Acta Psychiatr Scand; 2012 Apr; 125(4):309-17. PubMed ID: 21848702
[TBL] [Abstract][Full Text] [Related]
20. [Long-term effects of the treatment with risperidone versus conventional neuroleptics on the neuropsychological performance of euthymic bipolar patients].
Reinares M; Martínez-Arán A; Colom F; Benabarre A; Salamero M; Vieta E
Actas Esp Psiquiatr; 2000; 28(4):231-8. PubMed ID: 11116794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
